{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:53:01Z","timestamp":1774003981694,"version":"3.50.1"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2021J277"],"award-info":[{"award-number":["2021J277"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ncrna.2025.12.004","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:05:03Z","timestamp":1767686703000},"page":"150-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic roles of long non-coding RNAs in gastric cancer therapy resistance"],"prefix":"10.1016","volume":"17","author":[{"given":"Jiayi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8766-1876","authenticated-orcid":false,"given":"Juanmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib1","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000518483","article-title":"Epidemiological trends and future perspectives of gastric cancer in Eastern Asia","volume":"103","author":"Sekiguchi","year":"2022","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","article-title":"lincRNAs: genomics, evolution, and mechanisms","volume":"154","author":"Ulitsky","year":"2013","journal-title":"Cell"},{"issue":"7414","key":"10.1016\/j.ncrna.2025.12.004_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2025.12.004_bib7","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.1093\/nar\/gkaa1046","article-title":"NONCODEV6: an updated database dedicated to long non-coding RNA annotation in both animals and plants","volume":"49","author":"Zhao","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ncrna.2025.12.004_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tig.2015.03.007","article-title":"The Landscape of long noncoding RNA classification","volume":"31","author":"St Laurent","year":"2015","journal-title":"Trends Genet."},{"issue":"4","key":"10.1016\/j.ncrna.2025.12.004_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ncrna.2025.12.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111389","article-title":"The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression","volume":"137","author":"Su","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ncrna.2025.12.004_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ncrna.2024.10.005","article-title":"Glycolysis regulated exosomal LINC01214 inhibited CD8(+) T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492\/PPP1R11 axis","volume":"10","author":"Ding","year":"2025","journal-title":"Noncoding RNA Res."},{"issue":"4","key":"10.1016\/j.ncrna.2025.12.004_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ncrna.2024.06.002","article-title":"New mechanism of LncRNA: in addition to act as a ceRNA","volume":"9","author":"Zhang","year":"2024","journal-title":"Noncoding RNA Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2025.12.004_bib13","doi-asserted-by":"crossref","first-page":"D1295","DOI":"10.1093\/nar\/gkab1035","article-title":"lncRNAfunc: a knowledgebase of lncRNA function in human cancer","volume":"50","author":"Yang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ncrna.2025.12.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2025.108551","article-title":"Molecular insights and emerging therapeutic perspectives of the lncRNA GAS5\/miR-21 axis in cancer, fibrosis, cardiovascular, and immune disorders","volume":"796","author":"Ahmad","year":"2025","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-016-0530-6","article-title":"Long noncoding RNAs in cancer: mechanisms of action and technological advancements","volume":"15","author":"Bartonicek","year":"2016","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib16","doi-asserted-by":"crossref","first-page":"C421","DOI":"10.1152\/ajpcell.00364.2021","article-title":"lncRNAs in mesenchymal differentiation","volume":"322","author":"De la Fuente-Hernandez","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jcb.30221","article-title":"The various regulatory functions of long noncoding RNAs in apoptosis, cell cycle, and cellular senescence","volume":"123","author":"Heydarnezhad Asl","year":"2022","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.703","article-title":"LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability","volume":"12","author":"Zhu","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12943-020-01299-y","article-title":"LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2025.12.004_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ncrna.2025.12.004_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by long noncoding RNAs","volume":"81","author":"Rinn","year":"2012","journal-title":"Annu. Rev. Biochem."},{"issue":"5992","key":"10.1016\/j.ncrna.2025.12.004_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-022-02319-z","article-title":"LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond","volume":"41","author":"Huang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-017-0612-0","article-title":"Linking long non-coding RNAs and SWI\/SNF complexes to chromatin remodeling in cancer","volume":"16","author":"Tang","year":"2017","journal-title":"Mol. Cancer"},{"issue":"7438","key":"10.1016\/j.ncrna.2025.12.004_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature11884","article-title":"Activating RNAs associate with Mediator to enhance chromatin architecture and transcription","volume":"494","author":"Lai","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-024-01591-0","article-title":"LncRNA-encoded peptides in cancer","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.ncrna.2025.12.004_bib30","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3892\/mmr.2025.13617","article-title":"Emerging role of circular RNAs in gastric cancer: from basic biology to clinical applications (Review)","volume":"32","author":"Wang","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ncrna.2025.12.004_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/nar\/gkv1367","article-title":"Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor","volume":"44","author":"Enuka","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ncrna.2025.12.004_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101351","article-title":"Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p\/EIF5A2 pathway","volume":"18","author":"Jiang","year":"2022","journal-title":"Transl. Oncol."},{"issue":"12","key":"10.1016\/j.ncrna.2025.12.004_bib37","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","article-title":"Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation","volume":"17","author":"Luo","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.ncrna.2025.12.004_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749129","article-title":"LncRNA FEZF1-AS1 promotes multi-drug resistance of gastric cancer cells via upregulating ATG5","volume":"9","author":"Gui","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ncrna.2025.12.004_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cac2.12534","article-title":"N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer","volume":"44","author":"Wang","year":"2024","journal-title":"Cancer Commun."},{"issue":"22","key":"10.1016\/j.ncrna.2025.12.004_bib40","article-title":"Chitosan-Gelatin-EGCG nanoparticle-meditated LncRNA TMEM44-AS1 silencing to activate the P53 signaling pathway for the synergistic reversal of 5-FU resistance in gastric cancer","volume":"9","author":"Zhou","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40170-022-00293-w","article-title":"Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism","volume":"10","author":"Ding","year":"2022","journal-title":"Cancer Metab."},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib42","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/cas.15453","article-title":"Long noncoding RNA OVAAL enhances nucleotide synthesis through pyruvate carboxylase to promote 5-fluorouracil resistance in gastric cancer","volume":"113","author":"Tan","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2424513","article-title":"lncRNA LINC02323 predicts adverse neoadjuvant chemotherapy outcomes of gastric cancer patients and regulates cell sensitivity to 5-fluorouracil by negatively modulating miR-139-3p","volume":"56","author":"Chen","year":"2024","journal-title":"Ann. Med."},{"issue":"8","key":"10.1016\/j.ncrna.2025.12.004_bib44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(20)30315-6","article-title":"S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial","volume":"21","author":"Kang","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","article-title":"Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer","volume":"37","author":"Yang","year":"2022","journal-title":"J. Adv. Res."},{"issue":"22","key":"10.1016\/j.ncrna.2025.12.004_bib46","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/jcmm.17925","article-title":"Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway","volume":"27","author":"Luo","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.ncrna.2025.12.004_bib47","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052124","article-title":"Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer","volume":"22","author":"Xin","year":"2021","journal-title":"EMBO Rep."},{"issue":"24","key":"10.1016\/j.ncrna.2025.12.004_bib48","article-title":"M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-017-0743-3","article-title":"Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer","volume":"16","author":"YiRen","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2025.12.004_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117280","article-title":"Propofol facilitates cisplatin sensitivity via lncRNA MALAT1\/miR-30e\/ATG5 axis through suppressing autophagy in gastric cancer","volume":"244","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41419-019-1585-2","article-title":"Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41389-022-00441-3","article-title":"DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance","volume":"11","author":"Wang","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ncrna.2025.12.004_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148900","article-title":"lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel","volume":"932","author":"Naseri","year":"2025","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","article-title":"LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis","volume":"35","author":"Xu","year":"2023","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/1120009X.2023.2203606","article-title":"LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis","volume":"36","author":"Xiang","year":"2024","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jcmm.13970","article-title":"The contrary functions of lncRNA HOTAIR\/miR-17-5p\/PTEN axis and Shenqifuzheng injection on chemosensitivity of gastric cancer cells","volume":"23","author":"Jia","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ncrna.2025.12.004_bib57","article-title":"The FENDRR\/FOXC2 axis contributes to multidrug resistance in gastric cancer and correlates with poor prognosis","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"28","key":"10.1016\/j.ncrna.2025.12.004_bib58","article-title":"APAF1-Binding long noncoding RNA promotes tumor growth and multidrug resistance in gastric cancer by blocking apoptosome assembly","volume":"9","author":"Wang","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"10","key":"10.1016\/j.ncrna.2025.12.004_bib59","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.7150\/jca.65871","article-title":"The lncRNA CRNDE is regulated by E2F6 and sensitizes gastric cancer cells to chemotherapy by inhibiting autophagy","volume":"13","author":"Zhang","year":"2022","journal-title":"J. Cancer"},{"issue":"22","key":"10.1016\/j.ncrna.2025.12.004_bib60","doi-asserted-by":"crossref","first-page":"13558","DOI":"10.18632\/aging.205329","article-title":"Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation","volume":"15","author":"Wang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ncrna.2025.12.004_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100936","article-title":"Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer","volume":"68","author":"Qu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ncrna.2025.12.004_bib62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2022.03.026","article-title":"Functional role of the SLC7A11-AS1\/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism","volume":"184","author":"Luo","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"15","key":"10.1016\/j.ncrna.2025.12.004_bib63","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/CM9.0000000000002869","article-title":"RP11-789C1.1 inhibits gastric cancer cell proliferation and accelerates apoptosis via the ATR\/CHK1 signaling pathway","volume":"137","author":"Liu","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"11","key":"10.1016\/j.ncrna.2025.12.004_bib64","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1080\/15476286.2019.1709296","article-title":"The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505\/CYLD\/AKT axis in human gastric cancer cells","volume":"17","author":"Wang","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib65","article-title":"LncRNA and its role in gastric cancer immunotherapy","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ncrna.2025.12.004_bib67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.ncrna.2025.12.004_bib68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12885-021-09062-2","article-title":"A new risk model based on a 11-m(6)A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer","volume":"22","author":"Lei","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ncrna.2025.12.004_bib70","article-title":"The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib71","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12935-020-01173-3","article-title":"Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1\/PD-L1 immunotherapy and outcomes in patients with gastric cancer","volume":"20","author":"Ren","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ncrna.2025.12.004_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736682","article-title":"A ferroptosis-related lncRNAs signature predicts prognosis and therapeutic response of gastric cancer","volume":"9","author":"Xiao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.797339","article-title":"LncRNAs Target Ferroptosis-Related genes and impair activation of CD4(+) T cell in gastric cancer","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.739509","article-title":"Integrated analysis of stemness-related LncRNAs helps predict the immunotherapy responsiveness of gastric cancer patients","volume":"9","author":"Jiang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib75","article-title":"LncRNAs in serum-derived extracellular vesicles are potential biomarker and correlated with immune infiltration in gastric cancer","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.ncrna.2025.12.004_bib76","doi-asserted-by":"crossref","first-page":"25453","DOI":"10.18632\/aging.203765","article-title":"A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients","volume":"13","author":"Gao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ncrna.2025.12.004_bib77","article-title":"Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib78","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.2147\/OTT.S251625","article-title":"LncRNA SNHG15 contributes to immuno-escape of gastric cancer through targeting miR141\/PD-L1","volume":"13","author":"Dang","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"24","key":"10.1016\/j.ncrna.2025.12.004_bib79","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1002\/cam4.3544","article-title":"LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.ncrna.2025.12.004_bib80","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2021.03.022","article-title":"Redefining macrophage and neutrophil biology in the metastatic cascade","volume":"54","author":"Guc","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156137","article-title":"EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p","volume":"135","author":"Yi","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ncrna.2025.12.004_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017745","article-title":"MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib84","article-title":"lncRNA\/miR-29c-Mediated high expression of LOX can influence the immune status and chemosensitivity and can forecast the poor prognosis of gastric cancer","volume":"9","author":"Nai","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"22","key":"10.1016\/j.ncrna.2025.12.004_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225313","article-title":"Long non-coding RNA LOC339059 attenuates IL-6\/STAT3-Signaling-Mediated PDL1 expression and macrophage M2 polarization by interacting with c-Myc in gastric cancer","volume":"15","author":"Han","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib86","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/tox.23862","article-title":"Tumor-derived exosome ElNF1-AS1 affects the progression of gastric cancer by promoting M2 polarization of macrophages","volume":"38","author":"Ma","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2022.03.120","article-title":"LINC00665 interacts with BACH1 to activate Wnt1 and mediates the M2 polarization of tumor-associated macrophages in GC","volume":"146","author":"Yang","year":"2022","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ncrna.2025.12.004_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70600","article-title":"The MIR181A2HG\/miR-5680\/VCAN-CD44 axis regulates gastric cancer lymph node metastasis by promoting M2 macrophage polarization","volume":"14","author":"Zang","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.ncrna.2025.12.004_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ncrna.2024.07.004","article-title":"Targeting LINC00665\/miR-199b-5p\/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K\/AKt pathway","volume":"10","author":"Wang","year":"2025","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.ncrna.2025.12.004_bib90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1476-4598-13-92","article-title":"Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer","volume":"13","author":"Liu","year":"2014","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib91","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1568009620666200504114000","article-title":"HOTAIR competitively binds MiRNA330 as a molecular sponge to increase the resistance of gastric cancer to trastuzumab","volume":"20","author":"Bie","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47961-5","article-title":"Long noncoding RNA NONHSAT160169.1 promotes resistance via hsa-let-7c-3p\/SOX2 axis in gastric cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib93","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.18632\/aging.204078","article-title":"LncRNA CRART16\/miR-122-5p\/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression","volume":"14","author":"Zhang","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"10389","key":"10.1016\/j.ncrna.2025.12.004_bib94","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ncrna.2025.12.004_bib95","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ncrna.2025.12.004_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2018.05.007","article-title":"A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer","volume":"100","author":"Sahin","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.ncrna.2025.12.004_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103663","article-title":"Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials","volume":"9","author":"Lordick","year":"2024","journal-title":"ESMO Open"},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib98","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/annonc\/mdz199","article-title":"A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study","volume":"30","author":"Tureci","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ncrna.2025.12.004_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231217967","article-title":"Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer","volume":"16","author":"Kubota","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"9","key":"10.1016\/j.ncrna.2025.12.004_bib100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12032-024-02455-w","article-title":"Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay","volume":"41","author":"Elimam","year":"2024","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.ncrna.2025.12.004_bib101","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2023.02.044","article-title":"A liquid biopsy signature for the early detection of gastric cancer in patients","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ncrna.2025.12.004_bib102","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/gutjnl-2024-333657","article-title":"Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer","volume":"74","author":"Guo","year":"2025","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib103","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/gutjnl-2024-333522","article-title":"Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study","volume":"74","author":"Cai","year":"2025","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ncrna.2025.12.004_bib104","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12967-024-05554-4","article-title":"A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer","volume":"22","author":"Grillone","year":"2024","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2025.12.004_bib105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00404-017-4293-0","article-title":"A phase 1\/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian\/peritoneal cancer","volume":"295","author":"Lavie","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib106","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.juro.2013.12.011","article-title":"DNA based therapy with diphtheria toxin-A BC-819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer","volume":"191","author":"Gofrit","year":"2014","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib107","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/cgt.2012.10","article-title":"Phase 1\/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer","volume":"19","author":"Hanna","year":"2012","journal-title":"Cancer Gene Ther."},{"issue":"7","key":"10.1016\/j.ncrna.2025.12.004_bib108","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.cell.2025.01.034","article-title":"Reprogrammable RNA-targeting CRISPR systems evolved from RNA toxin-antitoxins","volume":"188","author":"Zilberzwige-Tal","year":"2025","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ncrna.2025.12.004_bib109","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41589-024-01593-6","article-title":"Structures, mechanisms and applications of RNA-centric CRISPR-Cas13","volume":"20","author":"Yang","year":"2024","journal-title":"Nat. Chem. Biol."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:38:46Z","timestamp":1773995926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054025001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":109,"alternative-id":["S2468054025001374"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.12.004","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic roles of long non-coding RNAs in gastric cancer therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}